Clinical Study of Lipoic Acid on Ischemic Heart Failure

PHASE4CompletedINTERVENTIONAL

Enrollment

300

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

February 1, 2025

Study Completion Date

February 1, 2025

Conditions

Ischemic Heart Failure

Interventions

DRUG

Alpha-Lipoic Acid(α-LA)

200 mg, po, tid

DRUG

Placebos

200 mg, po, tid

Trial Locations (1)

Zhongshan Hospital, Shanghai

All Listed Sponsors

lead

Shanghai Zhongshan Hospital

OTHER

NCT03491969 - Clinical Study of Lipoic Acid on Ischemic Heart Failure | Biotech Hunter | Biotech Hunter